Skip to main content

Advertisement

Log in

Sensory signs and symptoms in women with self-reported breast cancer–related lymphedema: a case–control study close up

  • Published:
Journal of Cancer Survivorship Aims and scope Submit manuscript

A Correction to this article was published on 30 October 2021

This article has been updated

Abstract  

Purpose

It is not clear to what extent signs and symptoms other than arm swelling, including pain, altered sensory function, and body perception disturbances, differ between women with measurable and non-measurable breast cancer–related lymphedema (BCRL). A case-control study was performed to compare these signs and symptoms between (1) women with self-reported BCRL with objectively measurable swelling; (2) women with self-reported BCRL without objective confirmation; and (3) a control group with no self-reported BCRL.

Methods

The three groups were compared for (1) the severity of self-reported signs and symptoms of BCRL, (2) problems in functioning related to BCRL, (3) pain-related outcomes, (4) sensory functions, and (5) body perception.

Results

All self-reported outcomes related to signs and symptoms of BCRL and problems in functioning were significantly different between the control group and the other two groups with and without measurable self-reported BCRL (p < 0.001–0.003). Except for “skin texture” (p = 0.01), “hand swelling” (p=0.301) and ‘difficulty writing’ (p=0.676), no differences were found between groups. For pain-related outcomes, sensory function, and body perception, significant differences were only found for the mechanical detection threshold (p < 0.01) and self-reported disturbances in body perception (p < 0.001) between the self-reported BCRL groups and control group.

Conclusions

Diverse signs and symptoms related to BCRL, sensory function, and perception were different among women with self-reported BCRL compared to controls. No differences between women with and without measurable self-reported BCRL were found.

Implications for Cancer Survivors

The presence of self-reported BCRL, with or without measurable swelling, is a first indication for the need of further diagnostic evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Change history

References

  1. Disipio T, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–15.

    Article  PubMed  Google Scholar 

  2. Gebruers N, et al. Current and future perspectives on the evaluation, prevention and conservative management of breast cancer related lymphoedema: a best practice guideline. Eur J Obstet Gynecol Reprod Biol. 2017;216:245–53.

    Article  PubMed  Google Scholar 

  3. Damstra RJ, et al. The Dutch lymphedema guidelines based on the International Classification of Functioning, Disability, and Health and the chronic care model. J Vasc Surg Venous Lymphat Disord. 2017;5(5):756–65.

    Article  PubMed  Google Scholar 

  4. Gursen C, et al. Self-reported signs and symptoms of secondary upper limb lymphoedema related to breast cancer treatment: systematic review. Eur J Cancer Care (Engl). 2021. https://doi.org/10.1111/ecc.13440.

  5. Michelotti A, et al. Tackling the diversity of breast cancer related lymphedema: perspectives on diagnosis, risk assessment, and clinical management. Breast. 2019;44:15–23.

    Article  PubMed  Google Scholar 

  6. Armer J. Upper limb swelling following mastectomy: lymphedema or not? Oncology (Williston Park). 2007;21(4 Suppl):26–8.

    Google Scholar 

  7. Armer JM, et al. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res. 2003;52(6):370–9.

    Article  PubMed  Google Scholar 

  8. Bani HA, et al. Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit. Patient Educ Couns. 2007;66(3):311–8.

    Article  PubMed  Google Scholar 

  9. Fu MR, et al. Symptom report in detecting breast cancer-related lymphedema. Breast Cancer (Dove Med Press). 2015;7:345–52.

    Google Scholar 

  10. Mak SS, et al. Lymphedema and quality of life in Chinese women after treatment for breast cancer. Eur J Oncol Nurs. 2009;13(2):110–5.

    Article  CAS  PubMed  Google Scholar 

  11. Stubblefield MD, Keole N. Upper body pain and functional disorders in patients with breast cancer. PM R. 2013;6(2):170–83.

    Article  PubMed  Google Scholar 

  12. Stubblefield MD, Keole N. Upper body pain and functional disorders in patients with breast cancer. PM R. 2014;6(2):170–83.

    Article  PubMed  Google Scholar 

  13. Crosbie J, et al. Effects of mastectomy on shoulder and spinal kinematics during bilateral upper-limb movement. Phys Ther. 2010;90(5):679–92.

    Article  PubMed  Google Scholar 

  14. De Groef A, et al. Unraveling self-reported signs of central sensitization in breast cancer survivors with upper limb pain: prevalence rate and contributing factors. Pain Physician. 2018;21(3):E247-e256.

    Article  PubMed  Google Scholar 

  15. Goldberg JI, et al. Morbidity of sentinel node biopsy: relationship between number of excised lymph nodes and patient perceptions of lymphedema. Ann Surg Oncol. 2011;18(10):2866–72.

    Article  PubMed  Google Scholar 

  16. Terada M, et al. Patient-reported outcomes and objective assessments with arm measurement and bioimpedance analysis for lymphedema among breast cancer survivors. Breast Cancer Res Treat. 2020;179(1):91–100.

    Article  CAS  PubMed  Google Scholar 

  17. Sayko O, et al. Diagnosis and treatment of lymphedema after breast cancer: a population-based study. Pm & R. 2013;5(11):915–23.

    Article  Google Scholar 

  18. McLaughlin SA, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol. 2008;26(32):5220–6.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hayes SC, et al. Prevalence of upper-body symptoms following breast cancer and its relationship with upper-body function and lymphedema. Lymphology. 2010;43(4):178–87.

    CAS  PubMed  Google Scholar 

  20. Teo I, et al. Examining pain, body image, and depressive symptoms in patients with lymphedema secondary to breast cancer. Psycho-Oncology. 2015;24(11):1377–83 (Date of Publication: 01 Nov, 2015).

    Article  PubMed  Google Scholar 

  21. Lewis JS, et al. Body perception disturbance: a contribution to pain in complex regional pain syndrome (CRPS). Pain. 2007;133(1–3):111–9.

    Article  PubMed  Google Scholar 

  22. von Elm E, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–9.

    Article  Google Scholar 

  23. De Groef A, et al. Reliability and validity of a Dutch Lymphoedema Questionnaire: cross-cultural validation of the Norman Questionnaire. Eur J Cancer Care (Engl). 2020;29(4):e13242.

    Article  Google Scholar 

  24. De Vrieze T, et al. Revision of the Lymphedema Functioning, Disability and Health Questionnaire for Upper Limb Lymphedema (Lymph-ICF-UL): reliability and validity. Lymphat Res Biol. 2019;17(3):347–55.

    Article  PubMed  Google Scholar 

  25. Taylor R, et al. Reliability and validity of arm volume measurements for assessment of lymphedema. Phys Ther. 2006;86(2):205–14.

    Article  PubMed  Google Scholar 

  26. Gebruers N, et al. Volumetric evaluation of upper extremities in 250 healthy persons. Clin Physiol Funct Imaging. 2007;27(1):17–22.

    Article  CAS  PubMed  Google Scholar 

  27. Kahl C, Cleland JA. Visual analogue scale, numeric pain rating scale and the McGill pain Questionnaire: an overview of psychometric properties. Physical Therapy Reviews. 2005;10(2):123–8.

    Article  Google Scholar 

  28. Poquet N, Lin C. The Brief Pain Inventory (BPI). J Physiother. 2016;62(1):52.

    Article  PubMed  Google Scholar 

  29. VanDenKerkhof EG, et al. Sensitivity of the DN4 in screening for neuropathic pain syndromes. Clin J Pain. 2018;34(1):30–6. https://doi.org/10.1097/AJP.0000000000000512.

    Article  PubMed  Google Scholar 

  30. Rolke R, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain. 2006;123(3):231–43.

    Article  CAS  PubMed  Google Scholar 

  31. Mucke MCH, Radbruch L, Baron R, Maier C, Tolle T, Treede RD, Rolke R, Quantitative sensory testing (QST). English version. Schmerz. 2016. https://doi.org/10.1007/s00482-015-0093-2.

  32. Rolke RMW, Campbell KA, Schalber C, Caspari S, Birklein F, Treede RD. Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain. 2006;10(1):77–88.

    Article  CAS  PubMed  Google Scholar 

  33. Vilholm OJ, et al. Sensory function and pain in a population of patients treated for breast cancer. Acta Anaesthesiol Scand. 2009;53(6):800–6.

    Article  CAS  PubMed  Google Scholar 

  34. Norman SA, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27(3):390–7.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Norman SA, et al. Development and validation of a telephone questionnaire to characterize lymphedema in women treated for breast cancer. Phys Ther. 2001;81(6):1192–205.

    Article  CAS  PubMed  Google Scholar 

  36. Brunelle CL, et al. Integrating symptoms into the diagnostic criteria for breast cancer-related lymphedema: applying results from a prospective surveillance program. Phys Ther. 2020;100(12):2186–97.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Cornish BH, et al. Early diagnosis of lymphedema in postsurgery breast cancer patients. Ann N Y Acad Sci. 2000;904:571–5.

    Article  CAS  PubMed  Google Scholar 

  38. Barrio AV, Eaton A, Frazier TG. A prospective validation study of bioimpedance with volume displacement in early-stage breast cancer patients at risk for lymphedema. Annals of surgical oncology. 2015;22(Suppl 3(03)):370–5.

    Article  PubMed Central  Google Scholar 

  39. Dylke ES, et al. Diagnosis of upper limb lymphedema: development of an evidence-based approach. Acta Oncol. 2016;55(12):1477–83.

    Article  CAS  PubMed  Google Scholar 

  40. Mihara M, et al. Indocyanine green (ICG) lymphography is superior to lymphoscintigraphy for diagnostic imaging of early lymphedema of the upper limbs. PLoS ONE [Electronic Resource]. 2012;7(6):e38182.

    Article  CAS  Google Scholar 

  41. Dams L, et al. Quantitative sensory testing in women after surgery for breast cancer: a systematic review and narrative synthesis. Clin J Pain. 2021;37(7):538–64.

    Article  PubMed  Google Scholar 

  42. Baran E, et al. Upper limb sensory evaluations and ultrasonographic skin measurements in breast cancer-related lymphedema receiving complex decongestive physiotherapy. Support Care Cancer. 2021:1–9. https://doi.org/10.1007/s00520-021-06235-4.

  43. Morales-Sánchez L, et al. Enhancing self-esteem and body image of breast cancer women through interventions: a systematic review. Int Environ Res Public Health. 2021;18(4). https://doi.org/10.3390/ijerph18041640.

  44. Harvie DS, Edmond-Hank G, Smith AD. Tactile acuity is reduced in people with chronic neck pain. Musculoskelet Sci Pract. 2018;33:61–6.

    Article  PubMed  Google Scholar 

  45. Heathcote LC, Eccleston C. Pain and cancer survival: a cognitive-affective model of symptom appraisal and the uncertain threat of disease recurrence. Pain. 2017;158(7):1187–91.

    Article  CAS  PubMed  Google Scholar 

  46. Ghaffari F, et al. Patient-centred communication for women with breast cancer: Relation to body image perception. J Clin Nurs. 2020;29(23–24):4674–84.

    Article  PubMed  Google Scholar 

  47. Nijs J, et al. Pain following cancer treatment: guidelines for the clinical classification of predominant neuropathic, nociceptive and central sensitization pain. Acta Oncol. 2016;55(6):659–63.

    Article  PubMed  Google Scholar 

  48. Wang L, et al. Prevalence and intensity of persistent post-surgical pain following breast cancer surgery: a systematic review and meta-analysis of observational studies. Br J Anaesth. 2020;125(3):346–57.

    Article  PubMed  Google Scholar 

  49. Mustonen L, et al. What makes surgical nerve injury painful? A 4-year to 9-year follow-up of patients with intercostobrachial nerve resection in women treated for breast cancer. Pain. 2019;160(1):246–56.

    Article  PubMed  Google Scholar 

  50. Starkweather A, Lyon D, Schubert C. Pain and inflammation in women with early-stage breast cancer prior to induction of chemotherapy. Biol Res Nurs. 2011;15(2):234–41.

    Article  PubMed  CAS  Google Scholar 

  51. Torres Lacomba M, et al. Incidence of myofascial pain syndrome in breast cancer surgery: a prospective study. Clin J Pain. 2010;26(4):320–5.

    Article  PubMed  Google Scholar 

  52. De Groef A, et al. Effect of myofascial techniques for treatment of persistent arm pain after breast cancer treatment: randomized controlled trial. Clin Rehabil. 2018;32(4):451–61.

    Article  PubMed  Google Scholar 

  53. Edwards RR, et al. Alteration in pain modulation in women with persistent pain after lumpectomy: influence of catastrophizing. Journal of Pain & Symptom Management. 2013;46(1):30-42 13p.

    Article  Google Scholar 

  54. Verbelen H, et al. Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review. Breast Cancer Res Treat. 2014;144(1):21–31.

    Article  PubMed  Google Scholar 

  55. Temple LK, et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol. 2002;9(7):654–62.

    Article  PubMed  Google Scholar 

  56. Svensson BJ, et al. Screening for breast cancer-related lymphoedema: self-assessment of symptoms and signs. Support Care Cancer. 2020;28(7):3073–80.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to An De Groef.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

De Groef, A., Devoogdt, N., Gursen, C. et al. Sensory signs and symptoms in women with self-reported breast cancer–related lymphedema: a case–control study close up. J Cancer Surviv 16, 1096–1106 (2022). https://doi.org/10.1007/s11764-021-01100-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11764-021-01100-z

Keywords

Navigation